Story excerpt provided by Global Cardiovascular Innovation Center.
Written by Mark Low, Managing Director, GCIC.
At the 10th anniversary of the Center, companies supported have secured over $1Billion in new funding, over 1000 jobs have been created, and 25 new products are either in the market or in clinical trials serving patients worldwide. This is our story.
The Global Cardiovascular Innovation Center (GCIC) is a multi-institutional product development and commercialization consortium made possible through a $60 million grant from the State of Ohio’s Third Frontier Program. Founded in 2007, the consortium is led by the Cleveland Clinic and is comprised of Case Western Reserve.
University, The Ohio State University, The University of Cincinnati, The University of Toledo and University Hospitals of Cleveland along with economic development partners BioOhio, BioEnterprise, and Team Northeast Ohio. GCIC is focused on developing, incubating, and commercializing innovative cardiovascular technology for the benefit of patients worldwide and to facilitate economic development in the State of Ohio.
Click here to read the complete article.